由『現代化中醫藥國際協會(MCMIA)』主辦之「國際現代化中醫藥及健康產品會議（ICMCM）」於2022年8月11-12日假香港會議展覽中心N101B舉行。MCMIA感謝香港貿易發展局、所有籌委會成員及協辦單位的鼎力支助，使ICMCM 得以順利舉行。

今年ICMCM 的主題是「中藥創新藥物研發及臨床研究」，會議16位講者分別來自美國、奧地利、德國、澳洲、日本、中國內地及香港。會議將包括以下五個環節。(詳細議程，請參閱附件。)

·         主題演講

·         從中醫臨床到中藥新藥

·         最新中藥科研成果

·         產品商業化及成功個案分享

·         第十八屆國際研究生中醫藥研討會

重溫會議內容：

11/ 8 / 2022 (Thursday星期四)

ICMCM Opening Ceremony 開幕禮

點擊觀看 https://drive.google.com/file/d/16yTJhLZh2ppQwB_07nXXNHXYnOO4nvLC/view?usp=sharing

Session 1: Keynote Speech

第一節: 主題演講

點擊觀看 https://drive.google.com/file/d/1wGj3v0Gm_6scQoetRdBchdibfeQdMQoc/view?usp=sharing

(中文)

https://drive.google.com/file/d/100aPoUHFBqqF9YgQ2KhWwyCJCmxfP07A/view?usp=sharing

(英文)

Ø  未來醫學　融貫中西:WE Medicine

Case Study: YIV-906

Prof Yung-Chi Cheng, Henry Bronson Professor of Pharmacology and Medicine, Yale University 

美國耶魯大學醫學院藥理學系講座教授鄭永齊教授

Ø  從中醫藥尋找抗新冠藥物創新轉化的源泉

Professor Zifeng Yang, Associate Dean, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health

廣州醫科大學附屬第一醫院廣州呼吸健康研究院副院長 楊子峰教授

Ø  The basic and clinical research of anti-depressive effect of Lycium Bararum Glycopeptides

枸杞糖肽抗抑鬱的基礎研究和臨床實驗

Professor Kwok-Fai So, Jinan University, Guangdong-HongKong-Macau Institute of CNS Regeneration

暨南大學 粵港澳中樞神經再生研究院 蘇國輝教授

Session 2: From CM clinical studies to new CM products

第二節: 從中醫臨床到中藥新藥

點擊觀看 https://drive.google.com/file/d/1qAznBqyWK_RlOtAGHr94DL_pE-V40U83/view?usp=sharing

(中文)

https://drive.google.com/file/d/1xXtFvq4Qeu39ygPv2oAp9h-QdZD-jzi-/view?usp=sharing

(英文)

Ø  COVID-19 and Chinese Herbal Medicine – from clinical research to practical use

Professor Ka Kit Hui, UCLA Department of Medicine       

Ø  The impact of individual gut microbiota on activity of Chinese herbal medicine

Professor Rudolf Bauer, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria

Ø  Phytomedicine application in clinical practice

Professor Thomas Efferth, Johannes Gutenberg University, Institute of Pharmaceutical and Biomedical Sciences, Mainz, Germany

Ø  Chemical characterization of Prunella vulgaris Glycoconjugates and its anti-HSV Activities

夏枯草多糖複合物的化學表徵及抗皰疹病毒的活性研究

Dr Li Yang, Shanghai University of Traditional Chinese Medicine

上海中醫藥大學中藥學院 李洋博士

Session 3: R&D on Chinese Medicines

第三節: 最新中藥科研成果

點擊觀看 https://drive.google.com/file/d/1BuGpqxUiDBYfyKy2mQ4v-G927YuhyEhO/view?usp=sharing

(中文)

https://drive.google.com/file/d/1dqiiE8BCfcdVjUZFTSrXcidSdzH1PZW-/view?usp=sharing

(英文)

Ø  Basic and clinical research on the development of new anti-cancer drug elemene liposome based on the theory of “molecular compatibility” of integrated traditional Chinese and western medicine

中西醫結合“分子配伍”理論研發抗癌新藥欖香烯脂質體的基礎與臨床研究

杭州師範大學醫學院整合藥學院院長 謝恬教授

Ø  Effectiveness and mechanism of Liu-wei-di-huang-wan (Rehammnia-6)-based treatment for diabetic kidney disease

六味地黃丸治療糖尿病腎病的療效及機理

Dr Chan Kam Wa, Department of Medicine, School of Clinical Medicine, the University of Hong Kong

香港大學臨床醫學院 陳錦華博士

Ø  A RCT of application of Zishen Yutai Pill in IVF-ET

滋腎育胎丸在IVF-ET中應用的隨機對照臨床研究

Professor Yang Dongzi, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

中山大學孫逸仙紀念醫院 楊冬梓教授 

Ø  Development of a novel standardised herbal intervention for the treatment of vascular dementia 

Professor Dennis Chang, Director, NICM Health Research Institute, Western Sydney University, NSW, Australia

12/ 8 / 2022 (Friday星期五)

Session 4: Product Commercialization & Successful Cases Sharing

第四節:    產品商業化及成功個案分享

點擊觀看 https://drive.google.com/file/d/1SFEZF5NyTrA8SGIoS2g3sqRvwiOUrntD/view?usp=sharing

(中文)

https://drive.google.com/file/d/1y37Z7kraMn3oONU73xfJ3I0Rc8ggfyG8/view?usp=sharing

(英文)

Ø  GI research with Chinese herbal medicine, from clinical research to new drug discovery

中醫藥治療胃腸道疾病 – 從臨床研究到新藥研發

Professor Bian Zhao Xiang, Associate Vice-President (Chinese Medicine Development), Hong Kong Baptist University

香港浸會大學協理副校長 (中醫藥發展) 卞兆祥教授

Ø  Randomized, double-blind, and placebo-controlled clinical trials on rare Chinese medicinal materials: Red Ginseng and Ejiao

名貴中藥紅參及阿膠的隨機、雙盲臨床研究

Professor Li Zhang, Shanghai University of Traditional Chinese Medicine

上海中醫藥大學 張莉教授  

Ø  Adjuvant therapy of Coriolus versicolor extracts for cancer

雲芝提取物的癌症輔助治療

Dr Xiaoyu JI, R&D project coordinator, Purapharm Corporation Ltd 

培力(香港)健康產品有限公司研發項目統籌主任 季曉宇博士

Ø  Dendrobium Officinale and the Promotion and Development of Traditional Chinese Medicine Culture

鐵皮石斛與弘揚發展中醫藥文化

Mr Chen Lizuan, Director, Zhejiang Tianhuang Medicinal Plant Pharmaceutical Co.,Ltd

浙江天皇藥業有限公司董事長 陳立鑽先生   

Ø  Successful commercialization of an anti-aging ingredient based on advanced research: Latest advancement of SIRTMAX® (Kaempferia parviflora extract) in SIRT1 activation and clinical study

以高端科技為基礎抗衰老原料的成功開發以及產業化: SIRTMAX® (Kaempferia parviflora extract) 的SIRT1 活性化研究和臨床研究的最新進展

Dr Jin Tatsuzaki, President & CEO, TOKIWA Phytocamical Co., LTD

株式會社常磐植物化學研究所社長 & CEO 立崎 仁博士

Ø  Memorial lecture in memory of Dr. Albert Wong, Founding President of MCMIA

現代化中醫藥國際協會創會會長黃伯偉博士紀念演講

Professor Xu Hong Xi, Distinguished Professor, Shanghai University of Traditional Chinese Medicine

上海中醫藥大學中藥學院首席教授 徐宏喜教授

Session 5: The 18th International Postgraduate Symposium on Chinese Medicine

第五節: 第18屆國際研究生中醫藥研討會

點擊觀看 https://drive.google.com/file/d/1Ada3vm_DizDWT7io22jFoQRaJkK7K8fa/view?usp=sharing

(中文)

https://drive.google.com/file/d/13t94iDrNW8YFRo2aYB5-eZaujcO5DNoL/view?usp=sharing

(英文)

Ø  The 18th International Postgraduate Symposium on Chinese Medicine

第18屆國際研究生中醫藥研討會

Closing Remarks 閉幕總結